trending Market Intelligence /marketintelligence/en/news-insights/trending/yecel6miyzirsf38yx03rw2 content esgSubNav
In This List

The Medicines Co. appoints director

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

The Medicines Co. appoints director

Parsippany, N.J.-based biopharmaceutical company The Medicines Co. appointed Sarah Schlesinger to serve as an independent director, with immediate effect.

Schlesinger is chair of The Rockefeller University Hospital's institutional review board and a senior physician and associate professor of clinical investigation at the university.

She has worked in the field of cellular immunity for more than 20 years.